Skip to main content
logo
Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.70
-0.50 (-0.86%)
At close: Aug 18, 2026

Pet Pharm Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
265.54222.03130.7117.8775.74
Revenue Growth
19.60%69.88%10.89%55.62%-
Gross Profit
140.6116.4469.9664.5935.86
Operating Income
22.6214.748.117.59-4.84
Net Income
30.0324.9914.519.15-3.81
Earnings Per Share
0.510.450.350.30-0.16
EPS Growth
13.58%28.44%17.07%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
218.91518.86387.93168.4916.76
Total Debt
107.09106.16143.8848.242.52
Net Cash (Debt)
111.83412.7244.05120.29-25.77
Net Cash Growth
-72.90%69.11%102.89%--
Net Cash Per Share
1.937.545.903.99-1.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
69.1834.328.8820.75-17.83
Capital Expenditures
-24.96-29.51-188.4-12.68-10.04
Free Cash Flow
44.224.79-159.518.08-27.87
Free Cash Flow Growth
823.34%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
52.95%52.44%53.53%54.80%47.34%
Operating Margin
8.52%6.64%6.21%6.44%-6.39%
Pretax Margin
10.93%10.89%9.50%7.76%-5.03%
Profit Margin
11.31%11.25%11.10%7.76%-5.03%
FCF Margin
16.65%2.16%-122.05%6.85%-36.80%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.2460.2460.0890.194
Dividend Per Share Growth
183.61%177.68%-54.37%-
Dividend Yield
0.42%0.36%0.23%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
112.09143.47114.14--
P/FCF Ratio
75.80748.49---
PS Ratio
12.6216.1412.67--